Metastatic colorectal cancer in treatment failure: Regorafenib may prolong survival by a few weeks but at a cost of serious adverse effects
Patients with metastatic colorectal cancer who have exhausted their therapeutic options have a life expectancy of only a few months. Treatment is then based on tailored supportive care, without cytoto ...
read article